Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
At BW Primary Care, we want every patient, whether you are on Medicare or not, to understand what this program is, how it works, who it helps, and how our practice is preparing to support you through the rollout
Select a site in your rotation schedule
Yes, its a safe option when prescribed by a qualified medical professional
2005 Jan;75(1):39
Information last revised January 2026
Retatrutide (5mg / 10mg / 15mg / 30mg / 50mg) 4.88 out of 5 based on 16 customer ratings 49,99 159,99 Price range: 49,99 through 159,99 Certificate of Analysis Third-party purity report for Retatrutide (5mg / 10mg / 15mg / 30mg / 50mg) (PDF) for same-day dispatch --:--:-- Same-day EU dispatch Tracked & discreet Third-party tested COA on every batch Secure checkout Card Apple/Google Pay crypto Retatrutide Europe Triple Receptor Agonist Peptide Retatrutide Europe (LY3437943) is a synthetic acylated peptide and first-in-class triple agonist of the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR), developed by Eli Lilly as a research candidate in metabolic disease pharmacology
US$ 19.98
US$ 20.98
US$ 25.43
US$ 24.10
US$ 25.61
US$ 26.41
US$ 26.82
US$ 26.15
